M. Singer, The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3), JAMA, vol.315, issue.8, pp.801-810, 2016.
DOI : 10.1001/jama.2016.0287

C. Fleischmann, Assessment of Global Incidence and Mortality of Hospital-treated 15. Hamitouche, N. et al. Population Pharmacokinetic-Pharmacodynamic Model of Oral Fludrocortisone and Intravenous Hydrocortisone in Healthy Volunteers, AAPS J, vol.19, pp.727-735, 2017.

R. N. Upton and D. R. Mould, Basic Concepts in Population Modeling, Simulation, and Model-Based Drug Development: Part 3???Introduction to Pharmacodynamic Modeling Methods, CPT: Pharmacometrics & Systems Pharmacology, vol.4, issue.1
DOI : 10.1016/S0009-9236(97)90160-0

, CPT Pharmacomet. Syst. Pharmacol, vol.3, p.88, 2014.

L. Sheiner and J. Wakefield, Population modelling in drug development

, Res, vol.8, pp.183-193, 1999.

A. N. Cat, The endothelial mineralocorticoid receptor regulates vasoconstrictor tone and blood pressure, The FASEB Journal, vol.24, issue.7, pp.2454-2463, 2010.
DOI : 10.1161/HYPERTENSIONAHA.107.088955

J. A. Whitworth, 9-alpha-Fluorocortisol-induced hypertension: a review, J

, Hypertens, vol.4, pp.133-139, 1986.

J. A. Whitworth, D. Saines, and R. Thatcher, DIFFERENTIAL BLOOD PRESSURE AND METABOLIC EFFECTS OF 9?-FLUOROCORTISOL IN MAN, Clinical and Experimental Pharmacology and Physiology, vol.39, issue.3, pp.351-354, 1983.
DOI : 10.1016/0026-0495(79)90201-4

D. Annane, Corticosteroids for treating sepsis, Cochrane Database of Systematic Reviews, vol.301, issue.12, p.2243, 2015.
DOI : 10.1002/14651858.CD002243.pub3
URL : https://hal.archives-ouvertes.fr/hal-01274237

W. I. Sligl, D. A. Milner, S. Sundar, W. Mphatswe, and S. R. Majumdar, Safety and Efficacy of Corticosteroids for the Treatment of Septic Shock: A Systematic Review and Meta???Analysis, Clinical Infectious Diseases, vol.49, issue.1, pp.93-101, 2009.
DOI : 10.1086/599343

P. C. Minneci, K. J. Deans, P. Q. Eichacker, and C. Natanson, The effects of steroids during sepsis depend on dose and severity of illness: an updated meta-analysis, Clinical Microbiology and Infection, vol.15, issue.4, pp.308-318, 2009.
DOI : 10.1111/j.1469-0691.2009.02752.x

M. Volbeda, Glucocorticosteroids for sepsis: systematic review with meta-analysis and trial sequential analysis, Intensive Care Medicine, vol.16, issue.3, pp.1220-1234, 2015.
DOI : 10.1186/cc1498

A. W. Norman, M. T. Mizwicki, and D. P. Norman, Steroid-hormone rapid actions, membrane receptors and a conformational ensemble model, Nature Reviews Drug Discovery, vol.3, issue.1, pp.27-41, 2004.
DOI : 10.1038/nrd1283

T. Rhen and J. A. Cidlowski, Antiinflammatory Action of Glucocorticoids ??? New Mechanisms for Old Drugs, New England Journal of Medicine, vol.353, issue.16, pp.1711-1723, 2005.
DOI : 10.1056/NEJMra050541

S. Viengchareun, The mineralocorticoid receptor: insights into its molecular and (patho)physiological biology, Nuclear Receptor Signaling, vol.4, 2007.
DOI : 10.1621/nrs.05012
URL : https://hal.archives-ouvertes.fr/inserm-00193515

L. A. Druce, C. M. Thorpe, and A. Wilton, Mineralocorticoid effects due to cortisol inactivation overload explain the beneficial use of hydrocortisone in septic shock, Medical Hypotheses, vol.70, issue.1, pp.56-60, 2008.
DOI : 10.1016/j.mehy.2007.04.031

K. L. Becker, Principles and Practice of Endocrinology and Metabolism, 2001.

C. W. Hicks, Efficacy of selective mineralocorticoid and glucocorticoid agonists in canine septic shock, Critical Care Medicine, vol.40, issue.1, 2012.
DOI : 10.1097/CCM.0b013e31822efa14
URL : http://europepmc.org/articles/pmc3242885?pdf=render

K. B. Hebbar, J. A. Stockwell, and J. Fortenberry, Clinical effects of adding fludrocortisone to a hydrocortisone-based shock protocol in hypotensive critically ill children, Intensive Care Medicine, vol.78, issue.3, pp.518-524, 2011.
DOI : 10.2223/JPED.912

F. Fadel, Aldosterone and Vascular Mineralocorticoid Receptors in Murine Endotoxic and Human Septic Shock*, Critical Care Medicine, vol.45, issue.9, 2017.
DOI : 10.1097/CCM.0000000000002462

C. Schmidt, B. Kurt, K. Höcherl, and M. Bucher, INHIBITION OF NF-??B ACTIVITY PREVENTS DOWNREGULATION OF ??1-ADRENERGIC RECEPTORS AND CIRCULATORY FAILURE DURING CLP-INDUCED SEPSIS, Shock, vol.32, issue.3, pp.239-246, 2009.
DOI : 10.1097/SHK.0b013e3181994752

M. Bucher, F. Kees, K. Taeger, and A. Kurtz, Cytokines down-regulate ??1-adrenergic receptor expression during endotoxemia, Critical Care Medicine, vol.31, issue.2, pp.566-571, 2003.
DOI : 10.1097/01.CCM.0000048621.36569.69

T. H. Marwick, Measurement of Strain and Strain Rate by Echocardiography, Journal of the American College of Cardiology, vol.47, issue.7, pp.1313-1327, 2006.
DOI : 10.1016/j.jacc.2005.11.063

S. F. Nagueh, Recommendations for the evaluation of left ventricular diastolic function by echocardiography, Eur. J. Echocardiogr. J. Work

, Cardiol, vol.10, pp.165-193, 2009.

R. J. Bauer, S. Guzy, and C. Ng, A survey of population analysis methods and software for complex pharmacokinetic and pharmacodynamic models with examples, The AAPS Journal, vol.9, issue.1, p.60, 2007.
DOI : 10.1208/aapsj0901007

A. Hill, The possible effects of the aggregation of the molecules of hemoglobin on its dissociation curves, J. Physiol, vol.40, p.iv?vii, 1910.

E. Comets, K. Brendel, and F. Mentré, Computing normalised prediction distribution errors to evaluate nonlinear mixed-effect models: The npde add-on package for R, Computer Methods and Programs in Biomedicine, vol.90, issue.2, pp.154-166, 2008.
DOI : 10.1016/j.cmpb.2007.12.002
URL : https://hal.archives-ouvertes.fr/inserm-00274332

, REFERENCES, vol.1

B. Laviolle, N. Nesseler, C. Massart, and E. Bellissant, Fludrocortisone and Hydrocortisone, Alone or in Combination, on In Vivo Hemodynamics and In Vitro Vascular Reactivity in Normal and Endotoxemic Rats, Journal of Cardiovascular Pharmacology, vol.63, issue.6, 2014.
DOI : 10.1097/FJC.0000000000000072
URL : https://hal.archives-ouvertes.fr/hal-01147027

F. Fadel, G. André-grégoire, B. Gravez, B. Bauvois, S. Bouchet et al.,

. Al, Aldosterone and Vascular Mineralocorticoid Receptors in Murine Endotoxic and Human Septic Shock Crit Care Med, 2017.

, Pharmacokinetics of oral fludrocortisone in septic shock, Br J Clin Pharmacol, vol.82, issue.6, pp.1509-1525, 2016.

B. Laviolle, D. Annane, C. Fougerou, and E. Bellissant, Gluco- and mineralocorticoid biological effects of a 7-day treatment with low doses of hydrocortisone and fludrocortisone in septic shock, Intensive Care Medicine, vol.15, issue.8, pp.1306-1320, 2012.
DOI : 10.1186/cc10262

D. Annane, V. Sébille, C. Charpentier, P. Bollaert, B. François et al., Effect of Treatment With Low Doses of Hydrocortisone and Fludrocortisone on Mortality in Patients With Septic Shock, JAMA, vol.288, issue.7, pp.862-71, 2002.
DOI : 10.1001/jama.288.7.862

N. Hamitouche, E. Comets, M. Ribot, J. Alvarez, E. Bellissant et al., Population Pharmacokinetic-Pharmacodynamic Model of Oral Fludrocortisone and Intravenous Hydrocortisone in Healthy Volunteers, The AAPS Journal, vol.19, issue.3, pp.727-762, 2017.
DOI : 10.1208/s12248-016-0041-9
URL : https://hal.archives-ouvertes.fr/hal-01518886

B. Laviolle, L. Maguet, P. Verdier, M. Massart, C. Donal et al., Biological and Hemodynamic Effects of Low Doses of Fludrocortisone and Hydrocortisone, Alone or in Combination, in Healthy Volunteers With Hypoaldosteronism, Clinical Pharmacology & Therapeutics, vol.22, issue.2, pp.183-90, 2010.
DOI : 10.1161/hy0102.099031
URL : https://hal.archives-ouvertes.fr/hal-00748193

M. Ribot, A. Polito, S. Grassin-delyle, D. Annane, and J. Alvarez, Human plasma quantification of fludrocortisone using liquid chromatography coupled with atmospheric pressure chemical ionization mass spectrometry after low-dosage administration, Clinica Chimica Acta, vol.420, pp.2013109-2013122
DOI : 10.1016/j.cca.2012.11.026

P. Chan, P. Jacqmin, M. Lavielle, L. Mcfadyen, and B. Weatherley, The use of the SAEM algorithm in MONOLIX software for estimation of population pharmacokinetic-pharmacodynamic-viral dynamics parameters of maraviroc in asymptomatic HIV subjects, Journal of Pharmacokinetics and Pharmacodynamics, vol.30, issue.6, pp.41-61, 2011.
DOI : 10.1023/B:JOPA.0000012998.04442.1f
URL : https://hal.archives-ouvertes.fr/hal-00637403

S. Beal, Ways to fit a PK model with some data below the quantification limit, J

P. Pharmacodyn, , pp.481-504, 2001.

G. Hempel, M. Karlsson, D. Alwis, N. Toublanc, J. Mcnay et al., Population pharmacokinetic?pharmacodynamic modeling of moxonidine using 24?hour ambulatory blood pressure measurements Available from, Clin Pharmacol Ther [Internet], vol.64, issue.98, pp.9-923690053, 1998.

E. Comets, K. Brendel, and F. Mentré, Computing normalised prediction distribution errors to evaluate nonlinear mixed-effect models: The npde add-on package for R. Comput Methods Programs Biomed, pp.154-66, 2008.
URL : https://hal.archives-ouvertes.fr/inserm-00274332

C. W. Seymour, V. X. Liu, T. J. Iwashyna, F. M. Brunkhorst, T. D. Rea et al., Assessment of Clinical Criteria for Sepsis, JAMA, vol.315, issue.8, pp.762-774, 2016.
DOI : 10.1001/jama.2016.0288

D. C. Références-angus, W. T. Linde-zwirble, J. Lidicker, G. Clermont, J. Carcillo et al., Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care, Critical Care Medicine, vol.29, issue.7, pp.1303-1310, 2001.
DOI : 10.1097/00003246-200107000-00002

D. -annane, Corticosteroid Treatment and Intensive Insulin Therapy for Septic Shock in Adults: A Randomized Controlled Trial, JAMA, vol.303, pp.341-348, 2010.

D. -annane, E. Bellissant, P. Bollaert, J. Briegel, M. Confalonieri et al., Corticosteroids in the Treatment of Severe Sepsis and Septic Shock in Adults, JAMA, vol.301, issue.22, pp.2362-2375, 2009.
DOI : 10.1001/jama.2009.815

D. -annane, E. Bellissant, P. E. Bollaert, J. Briegel, D. Keh et al., , 2004.

, Corticosteroids for severe sepsis and septic shock: a systematic review and metaanalysis, BMJ, vol.329, p.480

D. -annane, E. Bellissant, P. E. Bollaert, J. Briegel, D. Keh et al., , 2015.

, Corticosteroids for treating sepsis, Cochrane Database Syst. Rev, vol.12, p.2243

D. -annane, E. Bellissant, and J. And-cavaillon, Septic shock, The Lancet, vol.365, issue.9453, pp.63-78, 2005.
DOI : 10.1016/S0140-6736(04)17667-8

D. -annane, E. Bellissant, V. Sebille, O. Lesieur, B. Mathieu et al., Impaired pressor sensitivity to noradrenaline in septic shock patients with and without impaired adrenal function reserve, British Journal of Clinical Pharmacology, vol.329, issue.6, pp.589-597, 1998.
DOI : 10.1056/NEJM199312303292706

D. -annane, V. Maxime, F. Ibrahim, J. C. Alvarez, E. Abe et al., , 2006.

, Diagnosis of adrenal insufficiency in severe sepsis and septic shock, Am. J. Respir. Crit

, Care Med, vol.174, pp.1319-1326

D. -annane, V. Sébille, C. Charpentier, P. Bollaert, B. François et al., Effect of Treatment With Low Doses of Hydrocortisone and Fludrocortisone on Mortality in Patients With Septic Shock, JAMA, vol.288, issue.7, pp.862-871, 2002.
DOI : 10.1001/jama.288.7.862

D. -annane and T. Sharshar, Cognitive decline after sepsis, The Lancet Respiratory Medicine, vol.3, issue.1, pp.61-69, 2015.
DOI : 10.1016/S2213-2600(14)70246-2

W. -arlt, A. , and B. , Adrenal insufficiency, The Lancet, vol.361, issue.9372, pp.1881-1893, 2003.
DOI : 10.1016/S0140-6736(03)13492-7

J. M. -bailey, A. N. Makheja, J. Pash, and M. Verma, Corticosteroids suppress cyclooxygenase messenger RNA levels and prostanoid synthesis in cultured vascular cells, Biochemical and Biophysical Research Communications, vol.157, issue.3, pp.1159-1163, 1988.
DOI : 10.1016/S0006-291X(88)80995-1

J. -banda, R. Lakshmanan, S. P. Vvs, S. P. Gudla, and R. Prudhivi, A highly sensitive method for the quantification of fludrocortisone in human plasma using ultra-high-performance liquid chromatography tandem mass spectrometry and its pharmacokinetic application, Biomedical Chromatography, vol.877, issue.12, pp.1213-1219, 2015.
DOI : 10.1016/j.jchromb.2009.01.003

R. M. -bateman, M. D. Sharpe, E. , and C. G. , Bench-to-bedside review: Microvascular dysfunction in sepsis ?hemodynamics, oxygen transport, and nitric oxide, Critical Care, vol.7, issue.5, pp.359-373, 2003.
DOI : 10.1186/cc2353

R. J. -bauer, S. Guzy, and C. Ng, A survey of population analysis methods and software for complex pharmacokinetic and pharmacodynamic models with examples, 2007.

, AAPS J, vol.9, p.60

S. L. Beal, Ways to fit a PK model with some data below the quantification limit, 2001.

, J. Pharmacokinet. Pharmacodyn, vol.28, pp.481-504

K. L. -becker, Principles and Practice of Endocrinology and Metabolism, 2001.

E. -bellissant and D. Annane, Effect of hydrocortisone on phenylephrine??? mean arterial pressure dose-response relationship in septic shock, Clinical Pharmacology & Therapeutics, vol.68, issue.3, pp.293-303, 2000.
DOI : 10.1067/mcp.2000.109354

R. C. -bone, R. A. Balk, F. B. Cerra, R. P. Dellinger, A. M. Fein et al., Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in Sepsis, Chest, vol.101, issue.6, pp.1644-1655, 1992.
DOI : 10.1378/chest.101.6.1644

J. -briegel, W. Kellermann, H. Forst, M. Haller, M. Bittl et al., Low-dose hydrocortisone infusion attenuates the systemic inflammatory response syndrome. The Phospholipase A2 Study Group, Clin. Investig, vol.72, pp.782-787, 1994.

M. -bucher, F. Kees, K. Taeger, and A. Kurtz, Cytokines down-regulate ??1-adrenergic receptor expression during endotoxemia, Critical Care Medicine, vol.31, issue.2, pp.566-571, 2003.
DOI : 10.1097/01.CCM.0000048621.36569.69

A. N. -cat, V. Griol-charhbili, L. Loufrani, C. Labat, L. Benjamin et al., The endothelial mineralocorticoid receptor regulates vasoconstrictor tone and blood pressure, The FASEB Journal, vol.24, issue.7, pp.2454-2463, 2010.
DOI : 10.1161/HYPERTENSIONAHA.107.088955

P. L. -chan, P. Jacqmin, M. Lavielle, L. Mcfadyen, and B. Weatherley, The use of the SAEM algorithm in MONOLIX software for estimation of population pharmacokinetic-pharmacodynamic-viral dynamics parameters of maraviroc in asymptomatic HIV subjects, Journal of Pharmacokinetics and Pharmacodynamics, vol.30, issue.6, pp.41-61, 2011.
DOI : 10.1023/B:JOPA.0000012998.04442.1f

A. -charloux, E. Lonsdorfer-wolf, R. Richard, E. Lampert, M. Oswald-mammosser et al., A new impedance cardiograph device for the non-invasive evaluation of cardiac output at rest and during exercise: comparison with the "direct" Fick method, European Journal of Applied Physiology, vol.82, issue.4, pp.313-320, 2000.
DOI : 10.1007/s004210000226

J. -cohen, The immunopathogenesis of sepsis, Nature, vol.288, issue.6917, pp.885-891, 2002.
DOI : 10.1038/nature01023

-. Investigators, D. Annane, A. Cariou, V. Maxime, E. Azoulay et al., Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial, JAMA, vol.303, pp.341-348

E. -comets, K. Brendel, and F. Mentré, Computing normalised prediction distribution errors to evaluate nonlinear mixed-effect models: The npde add-on package for R, Computer Methods and Programs in Biomedicine, vol.90, issue.2, pp.154-166, 2008.
DOI : 10.1016/j.cmpb.2007.12.002

M. -confalonieri, R. Urbino, A. Potena, M. Piattella, P. Parigi et al., Hydrocortisone Infusion for Severe Community-acquired Pneumonia, American Journal of Respiratory and Critical Care Medicine, vol.171, issue.3, 2005.
DOI : 10.1001/archinte.164.6.637

, Respir. Crit. Care Med, vol.171, pp.242-248

S. -cornélie, E. Wiel, N. Lund, G. Lebuffe, C. Vendeville et al., , 2002.

, Cytosine-phosphate-guanine (CpG) motifs are sensitizing agents for lipopolysaccharide in toxic shock model, Intensive Care Med, vol.28, pp.1340-1347

L. -cronin, D. J. Cook, J. Carlet, D. K. Heyland, D. King et al., , 1995.

, Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature, Crit. Care Med, vol.23, pp.1430-1439

W. H. -daughaday, BINDING OF CORTICOSTEROIDS BY PLASMA PROTEINS. II. PAPER ELECTROPHORESIS AND EQUILIBRIUM PAPER ELECTROPHORESIS J. Clin. Invest, vol.12, issue.35, pp.1434-1438, 1956.

N. L. -dayneka, V. Garg, and W. J. Jusko, Comparison of four basic models of indirect pharmacodynamic responses, Journal of Pharmacokinetics and Biopharmaceutics, vol.29, issue.4, pp.457-478, 1993.
DOI : 10.1111/j.1365-2125.1990.tb03622.x

R. P. -dellinger, M. M. Levy, A. Rhodes, D. Annane, H. Gerlach et al., Surviving Sepsis Campaign, Critical Care Medicine, vol.41, issue.2, pp.165-228, 2012.
DOI : 10.1097/CCM.0b013e31827e83af

H. -derendorf, G. Hochhaus, B. Meibohm, H. Möllmann, and J. Barth, , 1998.

, Pharmacokinetics and pharmacodynamics of inhaled corticosteroids, J. Allergy Clin. Immunol, vol.101, pp.440-446

L. A. -druce, C. M. Thorpe, and A. Wilton, Mineralocorticoid effects due to cortisol inactivation overload explain the beneficial use of hydrocortisone in septic shock, Medical Hypotheses, vol.70, issue.1, pp.56-60, 2008.
DOI : 10.1016/j.mehy.2007.04.031

F. -fadel, G. André-grégoire, B. Gravez, B. Bauvois, S. Bouchet et al., Aldosterone and Vascular Mineralocorticoid Receptors in Murine Endotoxic and Human Septic Shock, Crit. Care Med, 2017.

C. -fleischmann, A. Scherag, N. K. Adhikari, C. S. Hartog, T. Tsaganos et al., Assessment of Global Incidence and Mortality of Hospital-treated Sepsis. Current Estimates and Limitations, American Journal of Respiratory and Critical Care Medicine, vol.8, issue.3, pp.259-272, 2016.
DOI : 10.1001/jama.2014.2637

D. F. -gaieski, J. M. Edwards, M. J. Kallan, and B. G. Carr, Benchmarking the Incidence and Mortality of Severe Sepsis in the United States*, Critical Care Medicine, vol.41, issue.5, pp.1167-1174, 2013.
DOI : 10.1097/CCM.0b013e31827c09f8

Y. -gonda, S. Hirata, K. Saitoh, Y. Aoki, M. Mohri et al., , 1993.

, Antithrombotic effect of recombinant human soluble thrombomodulin on endotoxininduced disseminated intravascular coagulation in rats, Thromb. Res, vol.71, pp.325-335

T. E. -group, EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units, Intensive Care Med, vol.30, pp.580-588, 2004.

N. -hamitouche, E. Comets, M. Ribot, J. Alvarez, E. Bellissant et al., Population Pharmacokinetic-Pharmacodynamic Model of Oral Fludrocortisone and Intravenous Hydrocortisone in Healthy Volunteers, The AAPS Journal, vol.19, issue.3, pp.727-735, 2017.
DOI : 10.1208/s12248-016-0041-9

R. -hardy, E. H. Rabbitt, A. Filer, P. Emery, M. Hewison et al., , 2008.

, Local and systemic glucocorticoid metabolism in inflammatory arthritis

, Dis, vol.67, pp.1204-1210

K. B. -hebbar, J. A. Stockwell, and J. D. Fortenberry, Clinical effects of adding fludrocortisone to a hydrocortisone-based shock protocol in hypotensive critically ill children, Intensive Care Medicine, vol.78, issue.3, pp.518-524, 2011.
DOI : 10.2223/JPED.912

G. -hempel, M. O. Karlsson, D. P. Alwis, N. Toublanc, J. Mcnay et al., Population pharmacokinetic-pharmacodynamic modeling of moxonidine using 24-hour ambulatory blood pressure measurements, Clinical Pharmacology & Therapeutics, vol.7, issue.6, 1998.
DOI : 10.1007/BF03220008

C. W. -hicks, D. A. Sweeney, R. L. Danner, P. Q. Eichacker, A. F. Suffredini et al., Efficacy of selective mineralocorticoid and glucocorticoid agonists in canine septic shock, Critical Care Medicine, vol.40, issue.1, 2012.
DOI : 10.1097/CCM.0b013e31822efa14

T. J. -iwashyna, C. R. Cooke, H. Wunsch, and J. M. Kahn, Population Burden of Long-Term Survivorship After Severe Sepsis in Older Americans, Journal of the American Geriatrics Society, vol.299, issue.6, pp.1070-1077, 2012.
DOI : 10.1001/jama.299.19.2294

T. J. Iwashyna, E. W. Ely, D. M. Smith, and K. M. Langa, Long-term Cognitive Impairment and Functional Disability Among Survivors of Severe Sepsis, JAMA, vol.304, issue.16, pp.1787-1794, 2010.
DOI : 10.1001/jama.2010.1553

D. -keh, T. Boehnke, S. Weber-cartens, C. Schulz, O. Ahlers et al., Immunologic and Hemodynamic Effects of ???Low-Dose??? Hydrocortisone in Septic Shock, American Journal of Respiratory and Critical Care Medicine, vol.167, issue.4, pp.512-520
DOI : 10.1001/archinte.1997.00440250031004

B. -laviolle, D. Annane, C. Fougerou, and E. Bellissant, Gluco- and mineralocorticoid biological effects of a 7-day treatment with low doses of hydrocortisone and fludrocortisone in septic shock, Intensive Care Medicine, vol.15, issue.8, pp.1306-1314, 2012.
DOI : 10.1186/cc10262

B. -laviolle, E. Donal, L. Maguet, P. Lainé, F. Bellissant et al., Low doses of fludrocortisone and hydrocortisone, alone or in combination, on vascular responsiveness to phenylephrine in healthy volunteers, British Journal of Clinical Pharmacology, vol.29, issue.2, pp.423-430, 2013.
DOI : 10.1007/s00134-003-1986-6

B. -laviolle, L. Maguet, P. Verdier, M. Massart, C. Donal et al., Biological and Hemodynamic Effects of Low Doses of Fludrocortisone and Hydrocortisone, Alone or in Combination, in Healthy Volunteers With Hypoaldosteronism, Clinical Pharmacology & Therapeutics, vol.22, issue.2, pp.183-190, 2010.
DOI : 10.1161/hy0102.099031

B. -laviolle, N. Nesseler, C. Massart, and E. Bellissant, Fludrocortisone and Hydrocortisone, Alone or in Combination, on In Vivo Hemodynamics and In Vitro Vascular Reactivity in Normal and Endotoxemic Rats, Journal of Cardiovascular Pharmacology, vol.63, issue.6, pp.488-496, 2014.
DOI : 10.1097/FJC.0000000000000072

R. -lefering and E. A. Neugebauer, Steroid controversy in sepsis and septic shock, Critical Care Medicine, vol.23, issue.7, pp.1294-1303, 1995.
DOI : 10.1097/00003246-199507000-00021

M. M. -levy, M. P. Fink, J. C. Marshall, E. Abraham, D. Angus et al., SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference, 2001.

, Crit. Care Med, vol.31, pp.1250-1256

G. S. -martin, D. M. Mannino, S. Eaton, and M. Moss, The Epidemiology of Sepsis in the United States from 1979 through 2000, New England Journal of Medicine, vol.348, issue.16, pp.1546-1554, 1979.
DOI : 10.1056/NEJMoa022139

S. -mcgee, Use of Corticosteroids in Treating Infectious Diseases, Archives of Internal Medicine, vol.168, issue.10, p.1034, 2008.
DOI : 10.1001/archinte.168.10.1034

J. C. -melby and W. W. Spink, Comparative Studies on Adrenal Cortical Function and Cortisol Metabolism in Healthy Adults and in Patients with Shock Due to Infection, Journal of Clinical Investigation, vol.37, issue.12, pp.1791-1798, 1958.
DOI : 10.1172/JCI103772

P. C. -minneci, K. J. Deans, P. Q. Eichacker, and C. Natanson, The effects of steroids during sepsis depend on dose and severity of illness: an updated meta-analysis, Clinical Microbiology and Infection, vol.15, issue.4, 2009.
DOI : 10.1111/j.1469-0691.2009.02752.x

, Clin. Microbiol. Infect, vol.15, pp.308-318

V. P. -mitsky, R. J. Workman, W. E. Nicholson, J. Vernikos, R. M. Robertson et al., A sensitive radioimmunoassay for fludrocortisone in human plasma, Steroids, vol.59, issue.9, pp.555-558, 1994.
DOI : 10.1016/0039-128X(94)90074-4

D. R. -mould, U. , and R. N. , Basic Concepts in Population Modeling, Simulation, and Model-Based Drug Development, CPT: Pharmacometrics & Systems Pharmacology, vol.32, issue.9, p.6, 2012.
DOI : 10.1007/s10928-005-0062-y

D. R. -mould, U. , and R. N. , Basic Concepts in Population Modeling, Simulation, and Model-Based Drug Development???Part 2: Introduction to Pharmacokinetic Modeling Methods, CPT: Pharmacometrics & Systems Pharmacology, vol.14, issue.4, p.38, 2013.
DOI : 10.1177/0091270010376965

N. -mukaida, C. C. Zachariae, G. L. Gusella, and K. Matsushima, , 1991.

, Dexamethasone inhibits the induction of monocyte chemotactic-activating factor production by IL-1 or tumor necrosis factor, J. Immunol, vol.146, pp.1212-1215

A. W. -norman, M. T. Mizwicki, N. , and D. P. , Steroid-hormone rapid actions, membrane receptors and a conformational ensemble model, Nature Reviews Drug Discovery, vol.3, issue.1, pp.27-41, 2004.
DOI : 10.1038/nrd1283

W. -oelkers, Adrenal Insufficiency, New England Journal of Medicine, vol.335, issue.16, pp.1206-1212, 1996.
DOI : 10.1056/NEJM199610173351607

W. -oelkers, S. Diederich, and V. Bähr, Diagnosis and therapy surveillance in Addison's disease? rapid adrenocorticotropin (ACTH) test and measurement of plasma ACTH, renin activity, and aldosterone, J. Clin. Endocrinol. Metab, vol.75, pp.259-264, 1992.

M. -oppert, R. Schindler, C. Husung, K. Offermann, K. Gräf et al., Low-dose hydrocortisone improves shock reversal and reduces cytokine levels in early hyperdynamic septic shock*, Critical Care Medicine, vol.33, issue.11, pp.2457-2464, 2005.
DOI : 10.1097/01.CCM.0000186370.78639.23

S. -pilkis and G. , Molecular Physiology of the Regulation of Hepatic Gluconeogenesis and Glycolysis, Annual Review of Physiology, vol.54, issue.1, pp.885-909, 1992.
DOI : 10.1146/annurev.ph.54.030192.004321

A. -polito, N. Hamitouche, M. Ribot, A. Polito, B. Laviolle et al., Pharmacokinetics of oral fludrocortisone in septic shock, British Journal of Clinical Pharmacology, vol.51, issue.Suppl, pp.1509-1516, 2016.
DOI : 10.5414/CP201789

H. -prigent, V. Maxime, and D. Annane, Science review: Mechanisms of impaired adrenal function in sepsis and molecular actions of glucocorticoids, Critical Care, vol.8, issue.4, pp.243-252, 2004.
DOI : 10.1186/cc2878

M. W. -radomski, R. M. Palmer, and S. Moncada, Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells., Proceedings of the National Academy of Sciences, vol.87, issue.24, pp.10043-10047, 1990.
DOI : 10.1073/pnas.87.24.10043

-. , P. M. Wilkins, K. B. Fuh, K. C. Haglund, U. Bulkley et al., The mesenteric hemodynamic response to circulatory shock: an overview, Shock Augusta Ga, vol.15, pp.329-343, 2001.

T. -rhen, C. , and J. A. , Antiinflammatory Action of Glucocorticoids ??? New Mechanisms for Old Drugs, New England Journal of Medicine, vol.353, issue.16, pp.1711-1723, 2005.
DOI : 10.1056/NEJMra050541

A. -rhodes, L. E. Evans, W. Alhazzani, M. M. Levy, M. Antonelli et al., Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016, Intensive Care Medicine, vol.22, issue.4, pp.304-377, 2017.
DOI : 10.1155/2015/532721

M. -ribot, A. Polito, S. Grassin-delyle, D. Annane, and J. Alvarez, Human plasma quantification of fludrocortisone using liquid chromatography coupled with atmospheric pressure chemical ionization mass spectrometry after low-dosage administration, Clinica Chimica Acta, vol.420, pp.109-113, 2013.
DOI : 10.1016/j.cca.2012.11.026

S. -rinaldi, C. Adembri, S. Grechi, D. Gaudio, and A. R. , Low-dose hydrocortisone during severe sepsis: Effects on microalbuminuria, Critical Care Medicine, vol.34, issue.9, pp.2334-2339, 2006.
DOI : 10.1097/01.CCM.0000233872.04706.BB

F. M. -rogerson, F. E. Brennan, and P. J. Fuller, Mineralocorticoid receptor binding, structure and function, Molecular and Cellular Endocrinology, vol.217, issue.1-2, pp.203-212, 2004.
DOI : 10.1016/j.mce.2003.10.021

S. -rohatagi, A. Bye, C. Falcoz, A. E. Mackie, B. Meibohm et al., Dynamic Modeling of Cortisol Reduction after Inhaled Administration of Fluticasone Propionate, The Journal of Clinical Pharmacology, vol.36, issue.Suppl A, pp.938-941, 1996.
DOI : 10.1002/j.1552-4604.1996.tb04206.x

S. -rohatagi, A. Bye, A. E. Mackie, and H. Derendorf, Mathematical modeling of cortisol circadian rhythm and cortisol suppression, European Journal of Pharmaceutical Sciences, vol.4, issue.6, pp.341-350, 1996.
DOI : 10.1016/S0928-0987(96)00174-1

S. -rohatagi, U. Täuber, K. Richter, and H. Derendorf, , 1996.

. Pharmacokinetic, Pharmacodynamic Modeling of Cortisol Suppression after Oral Administration of Fluocortolone, J. Clin. Pharmacol, vol.36, pp.311-314

P. M. -rothwell, Z. F. Udwadia, and P. G. Lawler, Cortisol response to corticotropin and survival in septic shock, The Lancet, vol.337, issue.8741, pp.582-583, 1991.
DOI : 10.1016/0140-6736(91)91641-7

C. -schmidt, B. Kurt, K. Höcherl, and M. Bucher, INHIBITION OF NF-??B ACTIVITY PREVENTS DOWNREGULATION OF ??1-ADRENERGIC RECEPTORS AND CIRCULATORY FAILURE DURING CLP-INDUCED SEPSIS, Shock, vol.32, issue.3, pp.239-246, 2009.
DOI : 10.1097/SHK.0b013e3181994752

M. Schorderet, Pharmacologie ? Des concepts fondamentaux aux applications thérapeutiques 3e édition (Paris: Editions Frison-Roche)

P. -seguin, E. Bellissant, L. Tulzo, Y. Laviolle, B. Lessard et al., Effects of epinephrine compared with the combination of dobutamine and norepinephrine on gastric perfusion in septic shock, Clinical Pharmacology & Therapeutics, vol.71, issue.5, pp.381-388, 2002.
DOI : 10.1067/mcp.2002.122471

P. -seguin, B. Laviolle, P. Guinet, I. Morel, Y. Mallédant et al., , 2006.

, Dopexamine and norepinephrine versus epinephrine on gastric perfusion in patients with septic shock: a randomized study, Crit. Care, vol.10, p.32

C. W. -seymour, V. X. Liu, T. J. Iwashyna, F. M. Brunkhorst, T. D. Rea et al., Assessment of Clinical Criteria for Sepsis, JAMA, vol.315, issue.8, pp.762-774, 2016.
DOI : 10.1001/jama.2016.0288

L. -sheiner, W. , and J. , Population modelling in drug development, Statistical Methods in Medical Research, vol.46, issue.3, pp.183-193, 1999.
DOI : 10.1007/BF02353487

L. B. -sheiner, B. Rosenberg, and K. L. Melmon, Modelling of individual pharmacokinetics for computer-aided drug dosage, Computers and Biomedical Research, vol.5, issue.5, pp.411-459, 1972.
DOI : 10.1016/0010-4809(72)90051-1

M. -singer, C. S. Deutschman, C. W. Seymour, M. Shankar-hari, D. Annane et al., The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3), JAMA, vol.315, issue.8, pp.801-810, 2016.
DOI : 10.1001/jama.2016.0287

W. I. -sligl, D. A. Milner, S. Sundar, W. Mphatswe, and S. R. Majumdar, Safety and Efficacy of Corticosteroids for the Treatment of Septic Shock: A Systematic Review and Meta???Analysis, Clinical Infectious Diseases, vol.49, issue.1, pp.93-101, 2009.
DOI : 10.1086/599343

C. L. -sprung, D. Annane, D. Keh, R. Moreno, M. Singer et al., , 2008.

, Hydrocortisone Therapy for Patients with Septic Shock, N. Engl. J. Med, vol.358, pp.111-124

S. C. -sweetman, Martindale: the complete drug reference, 2009.

C. -thiemermann, H. Ruetten, C. C. Wu, and J. R. Vane, The multiple organ dysfunction syndrome caused by endotoxin in the rat: attenuation of liver dysfunction by inhibitors of nitric oxide synthase, British Journal of Pharmacology, vol.26, issue.7, pp.2845-2851, 1995.
DOI : 10.1093/cvr/26.1.48

R. N. -upton and D. R. Mould, Basic Concepts in Population Modeling, Simulation, and Model-Based Drug Development: Part 3???Introduction to Pharmacodynamic Modeling Methods, CPT: Pharmacometrics & Systems Pharmacology, vol.4, issue.1, p.88, 2014.
DOI : 10.1016/S0009-9236(97)90160-0

B. -venkatesh, J. Cohen, I. Hickman, J. Nisbet, P. Thomas et al., , 2007.

, Evidence of altered cortisol metabolism in critically ill patients: a prospective study, Intensive Care Med, vol.33, pp.1746-1753

S. -viengchareun, L. Menuet, D. Martinerie, L. Munier, M. Pascual-le-tallec et al., The mineralocorticoid receptor: insights into its molecular and (patho)physiological biology, Nuclear Receptor Signaling, vol.4, 2007.
DOI : 10.1621/nrs.05012

W. Vogt, I. Fischer, S. Ebenroth, S. Appel, M. Knedel et al., Pharmacokinetics of 9 -fluorhydrocortisone]. Arzneimittelforschung, pp.1133-1143, 1971.

M. Volbeda, J. Wetterslev, C. Gluud, J. G. Zijlstra, I. C. Horst et al., Glucocorticosteroids for sepsis: systematic review with meta-analysis and trial sequential analysis, Intensive Care Medicine, vol.16, issue.3, pp.1220-1234, 2015.
DOI : 10.1186/cc1498
URL : https://link.springer.com/content/pdf/10.1007%2Fs00134-015-3899-6.pdf

J. A. -whitworth, A. Butkus, J. P. Coghlan, D. A. Denton, E. H. Mills et al., 9-Alpha-Fluorocortisol-lnduced Hypertension: A Review, Journal of Hypertension, vol.4, issue.2, pp.133-139, 1986.
DOI : 10.1097/00004872-198604000-00002

J. A. -whitworth, D. Saines, T. , and R. , DIFFERENTIAL BLOOD PRESSURE AND METABOLIC EFFECTS OF 9?-FLUOROCORTISOL IN MAN, Clinical and Experimental Pharmacology and Physiology, vol.39, issue.3, pp.351-354, 1983.
DOI : 10.1016/0026-0495(79)90201-4

-. , D. F. Winter, H. R. Duffull, and S. B. , Understanding the time course of pharmacological effect: a PKPD approach, Br. J. Clin. Pharmacol, vol.71, pp.815-823, 2011.

E. Ribot, M. Alvarez, J. Bellissant, E. Laviolle, and B. , Population Pharmacokinetic-Pharmacodynamic Model of Oral Fludrocortisone and Intravenous Hydrocortisone in Healthy Volunteers, Publications et abstracts publiés à partir de travaux réalisés Publications internationales -Hamitouche N, Comets, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01518886

A. *. -polito, N. *. Hamitouche, M. *. Ribot, A. Polito, B. Laviolle et al., Pharmacokinetics of oral fludrocortisone in septic shock, British Journal of Clinical Pharmacology, vol.51, issue.Suppl, 2016.
DOI : 10.5414/CP201789

K. Abstracts-hammas, N. Hamitouche, C. Palpacuer, F. Lainé, E. Bellissant et al.,

, Population pharmacodynamics analysis of effect of three increasing doses of fludrocortisone on phenylephrine-mean arterial pressure dose-response relationship in healthy volunteers. Oral Communication Abstracts, Fundam Clin Pharmacol, vol.31, pp.5-20, 2017.

B. -laviolle, S. Abergel, N. Hamitouche, C. Rousseau, and M. Ferrand-sorre,

J. Raguideau, R. Ruel, and E. Bellissant, Effects of ivabradine on hemodynamics and inflammation in LPS-induced endotoxemic shock in rats. Oral Communication Abstracts, Fundam Clin Pharmacol, vol.30, pp.5-24, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01310759

N. -hamitouche, M. Ribot, A. Polito, D. Annane, J. Alvarez et al., Population Pharmacokinetic/Pharmacodynamics Modeling of Fludrocortisone and Hydrocortisone, Administered Alone or in Combination, in Healthy Volunteers. Discussed Poster Abstracts, Fundam Clin Pharmacol, vol.29, pp.20-33, 2015.

M. -ribot, . Polito-and, N. Hamitouche, P. Ang, B. Laviolle et al., Population pharmacokinetic modeling of oral fludrocortisone in septic shock patients. Poster Abstracts, Fundam Clin Pharmacol, vol.29, pp.47-61, 2015.